REVCOVI
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Oct 2025)
What this means for you
Registered since 09 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87300981
- Registration number
- 5800819
- Mark type
- Stylized text
- Filed
- 13 Jan 2017
- Published for opposition
- 30 May 2017
- Registered
- 09 Jul 2019
- Attorney of record
- John Zaccaria
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immunodeficiencies, namely, adenosine deaminase deficiency
Owner
- UNIKERIS LIMITED, MANCHESTER, GB
- LEADIANT BIOSCIENCES LIMITED, LONDON, GB
- LEADIANT BIOSCIENCES LIMITED, LONDON, GB
- LEADIANT BIOSCIENCES LIMITED, LONDON, GB
Prosecution history
- 23 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 09 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Jun 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 May 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Apr 2019 — USE AMENDMENT FILED
- 14 May 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Apr 2019 — TEAS STATEMENT OF USE RECEIVED
- 22 Nov 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2018 — SOU EXTENSION 2 GRANTED